MD featured in TIME Magazine for third consecutive year; update outlines MedTech, IVD and defence initiatives
Lord's Mark Industries said its Founder, MD and CEO Dr. Sachidanand Upadhyay has featured in TIME Magazine for the third consecutive year, with appearances in the 2024, 2025 and 2026 editions.
By ScoutQuest · · 2 min read
- TIME Magazine feature
- featured for the third consecutive year, with appearances in the 2024, 2025 and 2026 editions
- US FDA registration
- US FDA registration for more than 200 surgical and hygiene products
- ARKALL Holdings partnership
- partnership with ARKALL Holdings across 28 Caribbean countries
What the update says
Lord's Mark Industries has informed the exchanges that its Founder, Managing Director and CEO Dr. Sachidanand Upadhyay has featured in TIME Magazine for the third consecutive year, with appearances in the 2024, 2025 and 2026 editions. The intimation, shared under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, describes the company's work across MedTech, advanced diagnostics, artificial intelligence and indigenous defence technology.
Healthcare and diagnostics
- An AI-powered, integrated haemodialysis ecosystem developed through Renalyx Healthcare Systems, combining an indigenous dialysis machine with artificial intelligence, connected technology and patient monitoring; it has MHRA registration for the dialysis system.
- The company has also secured MHRA registration for its in-vitro diagnostics (IVD) portfolio, which it says strengthens access to the United Kingdom and allied markets.
- The Biomescan Analytics Platform, which analyses the gut microbiome through whole-metagenome sequencing, has secured a manufacturing licence for Software as a Medical Device (SaMD).
- An AI-powered, radiation-free breast cancer screening wearable developed with the Centre for Materials for Electronic Technology (C-MET) has progressed towards final clinical trials across India, the USA and Europe, subject to clinical validation and regulatory approvals.
Manufacturing and global reach
- The company has expanded its Silvassa surgical manufacturing operations.
- It has secured US FDA registration for more than 200 surgical and hygiene products.
- A strategic partnership with ARKALL Holdings is aimed at strengthening healthcare infrastructure across 28 Caribbean countries.
- The TIME feature states that the company has completed a $1 million medtech shipment to the US, comprising Indian-developed remote patient monitoring and AI-based early-warning technologies.
Beyond healthcare
- Through Brahmastra, the company says it is advancing indigenous defence innovation.
- Work across solar lighting, smart infrastructure and green hydrogen is described as part of a broader vision spanning technology, sustainability and national development.
What a retail investor can take away
- The communication is about a recognition and about stated business milestones. The registrations mentioned are regulatory permissions to make or market products, and several projects are described as being at development, trial or approval stage.
- The update's own words for these projects are "advancing", "aims to" and "ambition", which signal plans and ongoing work rather than completed commercial outcomes.
- The feature itself is a profile of the promoter-MD and his stated vision; the company's financial picture is best judged from its results updates rather than from a recognition announcement.
Also from Lords Mark Industries
Defence arm showcases three flagship products; positioned to explore international markets
30 Oct 2026
US FDA registration for 200+ products; Silvassa expansion completed ahead of schedule
23 Oct 2026
Board to consider Rs. 100 Crore unsecured loan from promoter with option to convert into equity
19 Oct 2026
More numbers
- Caribbean countries covered by ARKALL Holdings partnership28
- Surgical and hygiene products with US FDA registrationmore than 200
- Medtech shipment completed to the US$1 million
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.